| Q47715943 | Amyloidogenesis of Tau protein |
| Q42714396 | Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition |
| Q44429258 | Anionic Micelles and Vesicles Induce Tau Fibrillization in Vitro |
| Q36964038 | Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure |
| Q41240079 | Binding of the three-repeat domain of tau to phospholipid membranes induces an aggregated-like state of the protein. |
| Q46858641 | C-terminal truncation modulates both nucleation and extension phases of tau fibrillization |
| Q35136746 | Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies |
| Q38287992 | Cell-based Models To Investigate Tau Aggregation |
| Q38350075 | Cellular factors modulating the mechanism of tau protein aggregation |
| Q45328065 | Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease |
| Q44555436 | Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles |
| Q42082255 | Conformational features of tau fibrils from Alzheimer's disease brain are faithfully propagated by unmodified recombinant protein |
| Q40199573 | Cytosine beta-D-arabinofuranoside used as a paradigm modifier to increase production of tau aggregates in a cellular model of tauopathy |
| Q30435267 | Cytoskeletal pathologies of Alzheimer disease |
| Q51263482 | Detection and Quantification Methods for Fibrillar Products of In Vitro Tau Aggregation Assays. |
| Q36609379 | Detection and quantification of tau aggregation using a membrane filter assay |
| Q47824973 | Development of tau PET Imaging Ligands and their Utility in Preclinical and Clinical Studies. |
| Q91583395 | Different Amyloid-β Self-Assemblies Have Distinct Effects on Intracellular Tau Aggregation |
| Q40891013 | Differential assembly of human tau isoforms in the presence of arachidonic acid |
| Q33296123 | Differentiating Alzheimer disease-associated aggregates with small molecules |
| Q38733357 | EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease. |
| Q42836387 | FTDP-17 tau mutations induce distinct effects on aggregation and microtubule interactions |
| Q41820128 | Formation and propagation of tau oligomeric seeds |
| Q36224314 | Fourier Transform Infrared (FTIR) Spectroscopy, Ultraviolet Resonance Raman (UVRR) Spectroscopy, and Atomic Force Microscopy (AFM) for Study of the Kinetics of Formation and Structural Characterization of Tau Fibrils |
| Q43662734 | Functional differences of tau isoforms containing 3 or 4 C-terminal repeat regions and the influence of oxidative stress |
| Q42061829 | GSK-3beta phosphorylation of functionally distinct tau isoforms has differential, but mild effects |
| Q28597211 | Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies |
| Q53317312 | Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein. |
| Q36874806 | Initiation of assembly of tau(273-284) and its ΔK280 mutant: an experimental and computational study. |
| Q39035486 | Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules |
| Q36368413 | Ligand electronic properties modulate tau filament binding site density |
| Q34074190 | Neuroinflammatory signaling upregulation in Alzheimer's disease |
| Q53236118 | Nonsaturable binding indicates clustering of tau on the microtubule surface in a paired helical filament-like conformation. |
| Q30481896 | Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants |
| Q36082071 | Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases |
| Q34579395 | Peroxynitrite-induced nitrative and oxidative modifications alter tau filament formation. |
| Q30504709 | Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport. |
| Q33287254 | Potency of a tau fibrillization inhibitor is influenced by its aggregation state |
| Q41940387 | Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures |
| Q31111749 | Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro |
| Q41484754 | Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport |
| Q42422246 | RNA Binds to Tau Fibrils and Sustains Template-Assisted Growth |
| Q47609800 | Rapid Anionic Micelle-mediated α-Synuclein Fibrillization in Vitro |
| Q27315041 | Simulated cytoskeletal collapse via tau degradation |
| Q45284384 | Site-specific pseudophosphorylation modulates the rate of tau filament dissociation |
| Q35840438 | Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model |
| Q35841983 | Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments |
| Q44116139 | Structure, stability, and aggregation of paired helical filaments from tau protein and FTDP-17 mutants probed by tryptophan scanning mutagenesis |
| Q40421137 | Tau 6D and 6P isoforms inhibit polymerization of full-length tau in vitro |
| Q46445872 | Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo |
| Q37238281 | Tau aggregation and toxicity in tauopathic neurodegenerative diseases |
| Q42429043 | Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology |
| Q48858275 | Tau-66: evidence for a novel tau conformation in Alzheimer's disease |
| Q36671491 | Template-assisted filament growth by parallel stacking of tau. |
| Q47137171 | The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In Vitro |
| Q30490027 | The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. |
| Q33880243 | The role of the lipid bilayer in tau aggregation |
| Q53532759 | The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model. |
| Q35604223 | Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein |
| Q35836408 | tau kinases in the rat heat shock model: possible implications for Alzheimer disease |